This SARS-CoV-2 Nucleocapsid antibody is un-conjugated
Application
ELISA, Western Blotting (WB)
Predicted Reactivity
Predicted reactivity based on immunogen sequence: SARS-CoV Nucleocapsid proteins: (100%)
Purification
SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleocapsid Antibody is affinity chromatography purified via peptide column.
Immunogen
Anti-SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleocapsid antibody was raised against a peptide corresponding to 17 amino acids near the center of SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleocapsid protein.
SARS-CoV-2 N
Reactivity: SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV)
ELISA, IF
Host: Human
Monoclonal
CR3009 (03-009)
unconjugated
Recombinant Antibody
Application Notes
SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleocapsid antibody can be used for the detection of SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleocapsid protein in ELISA. It will detect 4 ng of free peptide at 1 μg/mL.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleocapsid Antibody is supplied in PBS containing 0.02 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleocapsid antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed
Expiry Date
12 months
Ren, Irudayaraj: "Paper-Based Test for Rapid On-Site Screening of SARS-CoV-2 in Clinical Samples." in: Biosensors, Vol. 11, Issue 12, (2022) (PubMed).
Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019-20 coronavirus outbreak.